Literature DB >> 20587884

Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia.

Murali Subramanian1, Nalini Kilara, R Manjunath, Vijaya Mysorekar.   

Abstract

The nephrotic syndrome (NS) is a well documented complication of hematological malignancies. However, chronic myeloid leukemia (CML) is rarely complicated by the NS, and it occurs usually after allogenic stem cell transplantation or interferon alpha therapy for CML. The NS as a complication of untreated CML is also rare. We report a 31-year-old patient who presented with features of The NS. He was diagnosed to have CML one year ago and was on irregular treatment with imatinib mesylate. The renal biopsy and immunofluorescence revealed membrano-proliferative glomerulonephritis type I. The patient was retreated with imatinib mesylate and the NS resolved gradually over three months. This maybe the third case in literature of membrano-proliferative glomerulonephritis associated with CML.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587884

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  4 in total

1.  Cure of relapsing nephrosis by an allogeneic marrow graft for chronic myelogenous leukemia.

Authors:  Keisuke Sugimoto; Naoki Sakata; Shinsuke Fujita; Tomoki Miyazawa; Hitomi Nishi; Tsukasa Takemura; Mitsuru Okada
Journal:  Pediatr Nephrol       Date:  2013-02-23       Impact factor: 3.714

Review 2.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

3.  The incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experience.

Authors:  J Pavinic; M Miglinas
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

Review 4.  Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.

Authors:  Terry King-Wing Ma; Stephen P McAdoo; Frederick Wai Keung Tam
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.